Patients with Essential Hypertension Present Higher Levels of sE-Selectin and sVCAM-1 Than Normotensive Volunteers

Clinical and Experimental Hypertension

Volumn 25, Issue 8, 2003, Pages 517-523

  Palomo, Iván ^a   Marín, Patricio ^b   Alarcón, Marcelo ^a   Gubelin, Gilda ^c   Viñambre, Ximena ^c   Mora, Eduardo ^a   Icaza, Gloria ^a  

^a UNIVERSIDAD DE TALCA   (Chile)

^b HOSPITAL REGIONAL DE TALCA   (Chile)

^c Primary Health Care Clinics   (Chile)

Author keywords

Cell adhesion molecules; Endothelial cells; Essential hypertension

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL;

BLOOD PRESSURE; CASE-CONTROL STUDIES; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0344464835     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120025335     Document Type: Article

References (21)

1. Mimran A, Ribstein J, Du Cailar G. Microalbuminuria in essential hypertension. Curr Opin Nephrol Hypertens 1999; 8(3):359-363.
2. Berrios X, Jadue L, Zenteno J, Ross MI, Rodriguez H. Prevalence of risk factors for chronic diseases. A study in the general population of the metropolitan area, 1986-1987. Rev Med Chil 1990; 118(5):597-604.
3. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335(8692):765-774.
4. Nomura S, Kanazawa S, Fukuhara S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens 2002; 16(8):539-547.
5. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001; 14(6 Pt 2):44S-54S.
6. Kuroda YT, Komamura K, Tatsumi R, Mori K, Yoneda K, Katayama Y, Shigemoto S, Miyatake K, Hanafusa T. Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension. Am J Hypertens 2001; 14(9 Pt 1):868-872.
7. Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A, De Mattia G. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 1999; 34(4 Pt 1):568-573.
8. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157(21):2413-2446.
9. Liao D, Arnett DK, Tyroler HA, Riley WA, Chambless LE, Szklo M, Heiss G. Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 1999; 34(2):201-206.
10. Demerath E, Towne B, Blangero J, Siervogel RM. The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women. Ann Hum Biol 2001; 28(6):664-678.
11. Semaan HB, Gurbel PA, Anderson JL, Muhlestein JB, Carlquist JF, Horne BD, Serebruany VL. Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease. Cardiology 2000; 93(1-2):7-10.
12. Buemi M, Allegra A, Aloisi C, Corica F, Alonci A, Ruello A, Montalto G, Frisina N. Cold pressor test raises serum concentrations of ICAM-1, VCAM-1, and E-selectin in normotensive and hypertensive patients. Hypertension 1997; 30(4):845-847.
13. Blann AD, Tse W, Maxwell SJ, Waite MA. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994; 12(8):925-928.
14. Felmeden DC, Spencer CG, Belgore FM, Blann AD, Beevers DG, Lip GY. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens 2003; 16(1):11-20.
15. DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens 1997; 10(12 Pt 1):1335-1341.
16. Calabresi L, Gomaraschi M, Villa B, Omoboni L, Dmitrieff C, Franceschini G. Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol. Arterioscler Thromb Vasc Biol 2002; 22(4):656-661.
17. Preston RA, Ledford M, Materson BJ, Baltodano NM, Memon A, Alonso A. Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor. J Hypertens 2002; 20(5):871-877.
18. Parissis JT, Venetsanou KF, Mentzikof DG, Kalantzi MV, Georgopoulou MV, Chrisopoulos N, Karas SM. Plasma levels of soluble cellular adhesion molecules in patients with arterial hypertension. Correlations with plasma endothelin-1. Eur J Intern Med 2001; 12(4):350-356.
19. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999; 21(5-6):1009-1060.
20. Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999; 340(16):1221-1227.
21. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362(6423):801-809.